EPISODE · Nov 1, 2018 · 1H 16M
First Rounders: Christoph Lengauer
from First Rounders
Christoph Lengauer is a venture partner at Third Rock Ventures, the president of Celsius Therapeutics, and executive vice president at Blueprint Medicines. His conversation with Nature Biotechnology covers growing up in Austria, why he nearly gave up research for a career helping settle refugees, and his role in the Henrietta Lacks story. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
First Rounders: Christoph Lengauer
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.